Literature DB >> 24651915

Primary Sjögren's syndrome and risk of ischemic stroke: a nationwide study.

Chia-Hung Chiang1, Chia-Jen Liu, Ping-Jen Chen, Chin-Chou Huang, Chien-Yi Hsu, Wan-Leong Chan, Po-Hsun Huang, Tzeng-Ji Chen, Shing-Jong Lin, Jaw-Wen Chen, Hsin-Bang Leu.   

Abstract

Few studies are available on the risk of ischemic stroke after a diagnosis of primary Sjögren's syndrome (PSS). This study investigated whether PSS increased the risk of ischemic stroke in a large, nationwide cohort. Data for 4,276 patients who were newly diagnosed with PSS from 2000 to 2006 and who did not have a stroke prior to diagnosis of PSS were obtained from the Registry of Catastrophic Illness in Taiwan. For each PSS patient, data for ten controls (matched by age, gender, comorbidities, and enrollment date) without systemic autoimmune disease or previous stroke were obtained from the Longitudinal Health Insurance 2000 database. All study subjects were followed up from the date of enrollment until they developed ischemic stroke, died, or until the end of 2006, whichever was earliest. To investigate if PSS was an independent factor in determining the risk of developing ischemic stroke, a Cox regression model was used with adjustment for age, gender, and comorbid disorders. Among 4,276 PSS patients and 42,760 controls, 669 subjects (51 PSS patients and 618 controls) developed ischemic stroke during the mean 3.7-year follow-up period (interquartile range 2.2-5.2 years). Patients with PSS and controls had a similar incidence of ischemic stroke occurrence (3.17/1,000 vs. 3.90/1,000 person years). Multivariate analysis adjusted for baseline covariates indicated that PSS did not increase the risk of ischemic stroke (adjusted hazard ratio: 0.84, 95 % confidence interval: 0.63-1.12, P = 0.244). PSS is not associated with an increased risk of ischemic stroke subsequent to diagnosis.

Entities:  

Mesh:

Year:  2014        PMID: 24651915     DOI: 10.1007/s10067-014-2573-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  34 in total

1.  Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study.

Authors:  T Coates; J P Slavotinek; M Rischmueller; D Schultz; C Anderson; M Dellamelva; M R Sage; T P Gordon
Journal:  J Rheumatol       Date:  1999-06       Impact factor: 4.666

Review 2.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients.

Authors:  M Pérez-De-Lis; M Akasbi; A Sisó; P Diez-Cascon; P Brito-Zerón; C Diaz-Lagares; J Ortiz; R Perez-Alvarez; M Ramos-Casals; A Coca
Journal:  Lupus       Date:  2010-07       Impact factor: 2.911

4.  The spectrum of neurological involvement in Sjögren's syndrome.

Authors:  A P Andonopoulos; G Lagos; A A Drosos; H M Moutsopoulos
Journal:  Br J Rheumatol       Date:  1990-02

5.  Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors.

Authors:  Roberto Gerli; Gaetano Vaudo; Elena Bartoloni Bocci; Giuseppe Schillaci; Alessia Alunno; Filippo Luccioli; Raed Hijazi; Elmo Mannarino; Yehuda Shoenfeld
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

Review 6.  Treatment of primary Sjögren syndrome: a systematic review.

Authors:  Manuel Ramos-Casals; Athanasios G Tzioufas; John H Stone; Antoni Sisó; Xavier Bosch
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

Review 7.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

8.  Headache in primary Sjögren's syndrome: a prevalence study.

Authors:  F Gökçay; G Oder; N Celebisoy; A Gökçay; H Sirin; Y Kabasakal
Journal:  Acta Neurol Scand       Date:  2008-03-18       Impact factor: 3.209

9.  Influence of metabolic syndrome and general obesity on the risk of ischemic stroke.

Authors:  Hsin-Jen Chen; Chyi-Huey Bai; Wen-Ting Yeh; Hou-Chang Chiu; Wen-Harn Pan
Journal:  Stroke       Date:  2006-03-02       Impact factor: 7.914

Review 10.  Central nervous system disease in Sjögren's syndrome.

Authors:  D Escudero; P Latorre; M Codina; J Coll-Cantí; J Coll
Journal:  Ann Med Interne (Paris)       Date:  1995
View more
  6 in total

1.  Metabolic syndrome in Sjögren's syndrome patients: a relevant concern for clinical monitoring.

Authors:  Kristopherson Lustosa Augusto; Eloisa Bonfa; Rosa Maria Rodrigues Pereira; Cleonice Bueno; Elaine Pires Leon; Vilma Santos Trindade Viana; Sandra Gofinet Pasoto
Journal:  Clin Rheumatol       Date:  2015-09-14       Impact factor: 2.980

Review 2.  Cardiovascular Involvement in Sjögren's Syndrome.

Authors:  Fabiola Atzeni; Francesco Gozza; Giacomo Cafaro; Carlo Perricone; Elena Bartoloni
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

3.  Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with primary Sjögren's syndrome.

Authors:  Cem Ozisler; Hatice Kaplanoglu
Journal:  Clin Rheumatol       Date:  2018-10-17       Impact factor: 2.980

4.  Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.

Authors:  J Mofors; M Holmqvist; L Westermark; A Björk; M Kvarnström; H Forsblad-d'Elia; S Magnusson Bucher; P Eriksson; E Theander; T Mandl; M Wahren-Herlenius; G Nordmark
Journal:  J Intern Med       Date:  2019-06-17       Impact factor: 8.989

5.  Increased risk of coronary heart disease among patients with primary Sjögren's syndrome: a nationwide population-based cohort study.

Authors:  Xue-Fen Wu; Jing-Yang Huang; Jeng-Yuan Chiou; Huang-Hsi Chen; James Cheng-Chung Wei; Ling-Li Dong
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

6.  Increased risk of aortic aneurysm and dissection in patients with Sjögren's syndrome: a nationwide population-based cohort study in Taiwan.

Authors:  Yi-Da Tsai; Wu-Chien Chien; Shih-Hung Tsai; Chi-Hsiang Chung; Shi-Jye Chu; Sy-Jou Chen; Wen-I Liao; Chih-Jen Yang; Min-Tser Liao; Jen-Chun Wang
Journal:  BMJ Open       Date:  2018-09-21       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.